David Spaner

7.7k citations
123 papers · 4.8k · 1 hit paper · h-index 36

Impact in

  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research
    • Virus-based gene therapy research
  • Immunology top 1%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
    • Immunodeficiency and Autoimmune Disorders

Papers in

    • Chronic Lymphocytic Leukemia Research 56
    • Immune Cell Function and Interaction 20
    • Immunotherapy and Immune Responses 18
    • T-cell and B-cell Immunology 10

David Spaner

119 papers receiving 4.7k citations

David Spaner's Hit Papers

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells 2011 · 1.1k citations
1.1k0+5+10Years since publication2505007501000

Peers

David Spaner
Comparison fields: 5 of 117
  • Genetics 1.3k
  • Immunology 1.7k
  • Oncology 1.8k
  • Pathology and Forensic Medicine 856
  • Hematology 499
Replace Thierry Fest with:
Thierry Fest France
Steven H. Bernstein United States
Kamal D. Puri United States
Marc Schmitz Germany
Pearlie K. Epling‐Burnette United States
Wei Xu China
D Delia Italy
Walter C. Darbonne United States
Cornelius Miething Germany
Junya Kuroda Japan
David Spaner relative to Thierry Fest France Thierry Fest's profile →
Citations per field
00.5×1.7×
Thierry Fest · 1×
Citations per year

Countries citing papers authored by David Spaner

Since Specialization
Citations

This map shows the geographic impact of David Spaner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Spaner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Spaner more than expected).

Fields of papers citing papers by David Spaner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Spaner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Spaner. The network helps show where David Spaner may publish in the future.

Co-authors

The 25 scholars most cited alongside David Spaner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Spaner Line = papers co-authored together David Spaner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.

#Work
1
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells
Hit paper breakdown →
20111140
2 2006314
3 2009231
4 1989120
5 2010109
6 2010109
7 201696
8 200388
9 201381
10 201280
11 200476
12 200675
13 201071
14 200568
15 201266
16 201666
17 199962
18
Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
199961
19 200856
20 199854

About David Spaner

David Spaner is a scholar working on Genetics, Immunology, Pathology and Forensic Medicine, Molecular Biology and Oncology, having authored 123 papers that have together received 4.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (56 papers), Lymphoma Diagnosis and Treatment (36 papers), Immune Cell Function and Interaction (20 papers), Immunotherapy and Immune Responses (18 papers), T-cell and B-cell Immunology (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Viral-associated cancers and disorders (9 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Genetics (1.3k citations), Immunology (1.7k citations), Oncology (1.8k citations), Pathology and Forensic Medicine (856 citations) and Hematology (499 citations). David Spaner has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Yonghong Shi, Marybeth S. Hughes, Giao Q. Phan, Robert O. Carpenter, Wyndham H. Wilson, Steven A. Feldman, Mark E. Dudley, James N. Kochenderfer, James C. Yang and Irina Marić. Their work appears in journals such as Blood, The Journal of Immunology, Leukemia, Journal of Clinical Oncology and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact